Cell Impact AB (publ)
F:ICLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cell Impact AB (publ)
F:ICLA
|
SE |
|
I
|
InRob Tech Ltd
OTC:IRBL
|
US |
Multiples-Based Value
The Multiples-Based Value for Cell Impact AB (publ) (ICLA) under the Base Case is 0.0055 EUR. Compared with the current market price of 0.0445 EUR, the stock appears Overvalued by 88% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.